Baricitinib for relapsing giant cell arteritis: a prospective open-label 52-week pilot study.
Ann Rheum Dis. 2022 Jun;81(6):861-867. doi: 10.1136/annrheumdis-2021-221961. Epub 2022 Feb 21.
Ann Rheum Dis. 2022.
PMID: 35190385
Free PMC article.